CS270249B2 - Method of purine's new derivatives production - Google Patents

Method of purine's new derivatives production Download PDF

Info

Publication number
CS270249B2
CS270249B2 CS887057A CS705788A CS270249B2 CS 270249 B2 CS270249 B2 CS 270249B2 CS 887057 A CS887057 A CS 887057A CS 705788 A CS705788 A CS 705788A CS 270249 B2 CS270249 B2 CS 270249B2
Authority
CS
Czechoslovakia
Prior art keywords
purine
formula
fluoro
amino
threopentofuranosyl
Prior art date
Application number
CS887057A
Other languages
Czech (cs)
English (en)
Other versions
CS705788A2 (en
Inventor
Robert W Lambert
Joseph A Martin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878725466A external-priority patent/GB8725466D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CS705788A2 publication Critical patent/CS705788A2/cs
Publication of CS270249B2 publication Critical patent/CS270249B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CS887057A 1987-10-30 1988-10-25 Method of purine's new derivatives production CS270249B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878725466A GB8725466D0 (en) 1987-10-30 1987-10-30 Purine derivatives
GB888816612A GB8816612D0 (en) 1987-10-30 1988-06-13 Purine derivatives

Publications (2)

Publication Number Publication Date
CS705788A2 CS705788A2 (en) 1989-10-13
CS270249B2 true CS270249B2 (en) 1990-06-13

Family

ID=26292971

Family Applications (1)

Application Number Title Priority Date Filing Date
CS887057A CS270249B2 (en) 1987-10-30 1988-10-25 Method of purine's new derivatives production

Country Status (15)

Country Link
EP (1) EP0314011A3 (zh)
JP (1) JPH01149797A (zh)
CN (1) CN1038102A (zh)
AU (1) AU2416088A (zh)
CS (1) CS270249B2 (zh)
DK (1) DK603788A (zh)
FI (1) FI884954A (zh)
HU (1) HU199502B (zh)
IL (1) IL88138A0 (zh)
MC (1) MC1984A1 (zh)
NO (1) NO168037C (zh)
NZ (1) NZ226672A (zh)
PH (1) PH25577A (zh)
PT (1) PT88891B (zh)
YU (1) YU199688A (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310732A (en) * 1986-02-03 1994-05-10 The Scripps Research Institute 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis
US5106837A (en) * 1988-03-16 1992-04-21 The Scripps Research Institute Adenosine derivatives with therapeutic activity
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides
US4997926A (en) * 1987-11-18 1991-03-05 Scripps Clinic And Research Foundation Deaminase-stable anti-retroviral 2-halo-2',3'-dideoxy
CA1339964C (en) * 1988-03-16 1998-07-21 Dennis A. Carson Substituted adenine derivatives useful as therapeutic agents
NZ232912A (en) * 1989-03-17 1992-06-25 Oncogen Ltd Lp Synergistic composition of nucleoside derivatives for inhibiting hiv
US5034518A (en) * 1989-05-23 1991-07-23 Southern Research Institute 2-fluoro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl) adenine nucleosides
US5384310A (en) * 1989-05-23 1995-01-24 Southern Research Institute 2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions
HU906976D0 (en) * 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
DK1261350T3 (da) * 2000-02-18 2006-11-13 Southern Res Inst Fremgangsmåder til syntetisering af 2-chlor-9-(2-deoxy-2-fluor-beta-d-arabinofuranosyl)-9H-purin-6-amin
US6753322B2 (en) 2000-06-06 2004-06-22 Pfizer Inc 2-aminocarbonyl-9H-purine derivatives
US7528247B2 (en) 2001-08-02 2009-05-05 Genzyme Corporation Process for preparing purine nucleosides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340645C (en) * 1987-04-17 1999-07-13 Victor E. Marquez Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus

Also Published As

Publication number Publication date
AU2416088A (en) 1989-05-04
NO168037B (no) 1991-09-30
EP0314011A2 (de) 1989-05-03
NO168037C (no) 1992-01-08
PH25577A (en) 1991-08-08
PT88891B (pt) 1993-01-29
FI884954A0 (fi) 1988-10-27
FI884954A (fi) 1989-05-01
DK603788A (da) 1989-05-01
JPH01149797A (ja) 1989-06-12
DK603788D0 (da) 1988-10-28
NO884830D0 (no) 1988-10-28
CN1038102A (zh) 1989-12-20
HUT48270A (en) 1989-05-29
IL88138A0 (en) 1989-06-30
NO884830L (no) 1989-05-02
EP0314011A3 (de) 1990-04-11
NZ226672A (en) 1991-07-26
CS705788A2 (en) 1989-10-13
YU199688A (en) 1990-04-30
HU199502B (en) 1990-02-28
MC1984A1 (fr) 1989-11-23

Similar Documents

Publication Publication Date Title
DE3587500T2 (de) Tumorbehandlung bei Säugetieren.
US5583239A (en) Antimicrobial sterol conjugates
FI63946B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 5'deoxi-5-fluorcytidin och 5'-deoxi-5-fluor-uridin
FR2709754A1 (fr) Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale.
CS270249B2 (en) Method of purine's new derivatives production
AU602083B2 (en) Pyrimidine derivatives
US4882316A (en) Pyrimidine derivatives
GB2073752A (en) 2,6-diaminobularines
US5441932A (en) Sugar compounds for inhibition of the biosynthesis of sugar chains containing sialic acid
US4258033A (en) 2,6-Diaminonebularines
US3948885A (en) 5-Hydroxyl-1,2,3-triazole-4-carboxamide nucleoside
FR2499577A1 (fr) Nouvelles 1-(2-chloroethyl)-1-nitrosourees-3-substituees par un reste de sucre, utiles notamment comme agents antitumoraux et leur procede de preparation
WO1995018817A1 (fr) Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant
US4794115A (en) Method of treating hyperlipemia
US4554349A (en) Aralkyl and aralkenyl glycosides as inhibitors of antigen-specific T-cell proliferation
JPH0267295A (ja) プリン誘導体
JPS632279B2 (zh)
US4423073A (en) Fluorinated diaminopentene derivatives
CS203946B2 (en) Method of producing n1-glucofuranosid-6-yl-n 3-nitrosoureas
WO2008007027A1 (fr) Nouveaux derives de 5-thioxylopyranose
EP0060099A1 (en) Antiviral agents, their preparation and use
KR820001541B1 (ko) 치환 몰라노린 유도체의 제조방법
JPH05148292A (ja) 6−o−アルキルエルサマイシンa誘導体の製造法
FR2487359A1 (fr) 11a-amino-androstanes, leur preparation et compositions en contenant
JPH05163292A (ja) 3’及び/又は4’位の水酸基を化学修飾したエルサマイシンa誘導体の製造法